Characterization of extrachromosomal circular DNA associated with genomic repeat sequences in breast cancer
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35423 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Wenxiang Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Repetitive Sequences, Nucleic Acid, DNA, Circular, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ili & Jiangsu Joint Institute of Health.
Abstract (Originalsprache)
Extrachromosomal circular DNA (eccDNA) has emerged as a potential biomarker for disease due to its stable closed circular structure. However, the diagnostic utility of eccDNA remains underexplored. In this study, we demonstrate that the characteristics of eccDNA associated with genomic repetitive elements change in breast cancer patient tissues and plasma. These changes can serve as signatures for accurate cancer classification. We profiled eccDNA annotated to repeat elements across the genome in tissues and plasma, aggregating each repeat element to the superfamily and subfamily level. Our findings indicate that eccDNA associated with repetitive elements in cancer exhibits regular patterns of enrichment or depletion in specific elements, particularly at the family level. Additionally, these repeat element changes are present in different subtypes of breast cancer, correlated with varying hormone receptor expression. Although there are differences in the landscapes of eccDNA on repetitive elements between cancer tissues and paired plasma, the unique characteristics of eccDNA associated with repetitive sequences in the plasma of cancer patients facilitate better differentiation from normal individuals. These analyses reveal that changes in eccDNA associated with repeat sequences in human cancers can be used as diagnostic biomarkers for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
- Institute for AI in Medicine, School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing, China.
- The Friendship Hospital of Ili Kazakh Autonomous Prefecture, Ili & Jiangsu Joint Institute of Health, Yining, Xinjiang Uygur Autonomous Region, China.
- Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Information, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Endoscopy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Bingbo Zhou, Xiao Sun, Yunfei Bai
Förderung
- National Natural Science Foundation of China
- Ili & Jiangsu Joint Institute of Health
Zitieren
APA
Lu, W., Yao, L., Wang, Y., Li, F., Zhou, B., Ming, W., Jiang, Y., Liu, X., Liu, Y., Sun, X., Wang, Y., & Bai, Y. (2025). Characterization of extrachromosomal circular DNA associated with genomic repeat sequences in breast cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.35423
Vancouver
Lu W, Yao L, Wang Y, Li F, Zhou B, Ming W, et al. Characterization of extrachromosomal circular DNA associated with genomic repeat sequences in breast cancer. International Journal of Cancer. 2025. doi:10.1002/ijc.35423
BibTeX
@article{Lu2025,
author = {Lu, Wenxiang and Yao, Lingsong and Wang, Ying and Li, Fuyu and Zhou, Bingbo and Ming, Wenlong and Jiang, Yali and Liu, Xiaoan and Liu, Yun and Sun, Xiao and Wang, Yan and Bai, Yunfei},
title = {Characterization of extrachromosomal circular DNA associated with genomic repeat sequences in breast cancer},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35423}
}
EUVIMED